Investing.com – Hologic (NASDAQ: HOLX) reported first quarter EPS of $1.07, $0.16 better than the analyst estimate of $0.91. Revenue for the quarter came in at $1.07B versus the consensus estimate of $997.31M.

Guidance

Hologic sees FY 2023 EPS of $2.51-$2.81 versus the analyst consensus of $5.82.

Hologic sees FY 2023 revenue of $3.70B-$3.90B versus the analyst consensus of $4.77B.

Hologic’s stock price closed at $82.78. It is up 10.04% in the last 3 months and up 14.72% in the last 12 months.

Hologic saw 7 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Hologic’s stock price’s past reactions to earnings here.

According to InvestingPro, Hologic’s Financial Health score is “great performance“.

Check out Hologic’s , and Hologic’s financials here.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar